APLSuite: An Integrated Suite for CD4+ T Cell Epitope Prediction via Antigen Processing Likelihood
Abstract
Computational epitope prediction is a critical tool for exploring and understanding CD4+ T cell-mediated immune responses, a key aspect of adaptive immunity. While existing computational methods primarily focus on supervised learning approaches, they often overlook the essential role of antigen processing in determining binding specificity. To address this limitation, our group developed Antigen Processing Likelihood (APL), an algorithm that integrates crystallographic B-factor, solvent accessib...
Description / Details
Computational epitope prediction is a critical tool for exploring and understanding CD4+ T cell-mediated immune responses, a key aspect of adaptive immunity. While existing computational methods primarily focus on supervised learning approaches, they often overlook the essential role of antigen processing in determining binding specificity. To address this limitation, our group developed Antigen Processing Likelihood (APL), an algorithm that integrates crystallographic B-factor, solvent accessible surface area (SASA), hydrogen exchange protection factors (COREX), and sequence entropy. In this paper we introduce APLSuite, a comprehensive and lightweight software suite designed to streamline APL-based epitope prediction. APLSuite integrates distributed RESTful API services, a Python client for data aggregation and processing, a data science tool for efficient epitope computation, and a user-friendly graphical user interface for non-coding users. It provides a seamless and efficient pipeline for APL calculation and epitope prediction that can be finished in minutes with GPU-acceleration, which has not been implemented by existed tools. This flexible and extensible software suite is deployable on desktop and cloud environments, offering both guided and customizable workflows to meet diverse research needs in immunology research and immunotherapy development.
Source: arXiv:2606.02462v1 - http://arxiv.org/abs/2606.02462v1 PDF: https://arxiv.org/pdf/2606.02462v1 Original Link: http://arxiv.org/abs/2606.02462v1
Please sign in to join the discussion.
No comments yet. Be the first to share your thoughts!
Jun 2, 2026
Pharmaceutical Research
Biochemistry
0